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S St tu ud dy y D De es si ig gn n:: Retrospective study.
P Pu ur rp po os se e:: This study was designed to determine the effectiveness of bone mineral density measurement as a supplementary
tool for evaluation of osteogenic potential in patients with spinal fusion. To this end, we correlated bone mineral density
(BMD) with osteogenic potential from cultured mesenchymal stem cells (MSCs). 
O Ov ve er rv vi ie ew w o of f L Li it te er ra at tu ur re e:: Many studies have correlated osteogenic potential of in vitro cultured MSCs with aging or osteo-
porosis.
M Me et th ho od ds s: We studied twenty-five individuals with harvested bone marrow from the ilium during lumbar spinal surgery.
The BMD of the femoral neck was measured using dual energy X-ray absorptiometry prior to bone marrow aspiration, and
the osteoporotic group was classified as those with T-scores below-2.5. After MSCs were isolated from bone marrow, in
vitro induction of osteogenesis was performed. We analyzed the patient’s osteogenic potential from cultured MSCs such as
mineral deposition stain, bone alkaline phosphatase (ALP) activity and osteoblast-specific gene expression in RT-PCR.
R Re es su ul lt ts s:: On mineral staining, the osteoporotic group had a scanty matrix mineral deposition in contrast to the non-osteo-
porotic group. The expression of osteocalcin in the osteoporotic group was 1.5 to 3 times less than in the non-osteoporotic
group. At the 3
rd week after the induction of osteogenesis, the activity of ALP of cultured MSCs in the osteoporotic group
was lower than in the control group (mean, 45±19 u/L, in osteoporotic group vs 136±7 u/L in non-osteoporotic), and there
was a statistically significant and positive correlation between BMD & ALP (r=0.487, p=0.013).
C Co on nc cl lu us si io on ns s:: There is a positive correlation between BMD and osteogenic potential derived from MSCs. The measurement of
BMD can provide supplementary data for evaluating osteogenic potential clinically. 
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Introduction
Mesenchymal stem cells (MSCs) have an important role
in the repair of musculoskeletal tissues because they have
been shown to have the ability to differentiate into chondro-
cytes and the osteoblasts when re-implanted in vivo. Since
the development of the field of tissue engineering and mod-
ern repair concepts, it has been shown clinically that mobi-
lization and differentiation of these cells is important in the
repair of fracture-nonunion and bone defects. The impor-
tance of bone marrow-derived MSCs in the repair of vari-
ous tissues has been highlighted by their ability to differen-
tiate into mesenchymal tissue
1. In addition, according to and
various clinical studies
2-5, those cells from bone marrow can
be cultured and differentiated in vitro and utilized to diag-
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The decrease in osteogenic potential is the main manifes-
tation of bone loss in aging and in patients with osteoporo-
sis
6-9. Many studies have shown that the decrease in
osteogenic potential with aging is due to a reduction in the
number of osteogenic progenitor cells due to degeneration
of MSCs, which leads to a decreased number of mature
osteoblasts
7,10,11. Some studies, however, have shown that the
number and the differentiation capacity of osteogenic stem
cells is maintained with aging
12,13. 
The change in human bone mass caused by a break in the
coupling of bone formation to bone resorption influences
bone density. Over the past decade, bone density scanning
machines have come to be widely used for the evaluation of
patients at risk of osteoporosis. The most populated quanti-
tative method to examine the bone density of human clini-
cally is the dual energy X-ray absorptiometry, due to its
many advantages, such as short duration of the procedure,
low precision error, and low risk of radiation exposure
14.
The present study was designed to determine the effec-
tiveness of bone mineral density measurement as a supple-
mentary tool for evaluation of osteogenic potential in
patients with spinal fusion using correlation analysis
between bone mineral density and the osteogenic potential
from cultured mesenchymal stem cells (MSCs). 
Materials and Methods
1. Inclusion criteria 
Human bone marrow was obtained from the iliac crest of
twenty-five patients during lumbar spine surgery. The
patients were twenty one to seventy two years old; there
were 9 males and 16 females. The bone mineral density of
the femoral neck by Dual Energy X-ray Absorptiometry
(DEXA, Hologic
�, QDR-4500, USA) was measured preop-
eratively and the osteoporotic group was defined as those
who had a T-score below -2.5 points in the femoral neck.
The osteoporotic group consisted of 9 patients and the non-
osteoporotic, control group (T score above -2.5 points) con-
sisted of 16 patients. 
2. MSCs isolation and cultivation
A 14-gauge needle was used to penetrate the cortex of the
ilium, and five to eight milliliters of bone marrow was aspi-
rated into a syringe containing 100 units of heparin. The
aspirate was suspended with Dulbecco’s Modified Eagles
Medium-Low Glucose (DMEM-LG; Gibco
� BRL, Grand
Island, NY, USA) and centrifuged at  600 X g using a 70%
sperm gradient (PureSperm
�100). MSCs were plated onto
dishes (75 cm
2), mixed with DMEM-LG solution, strepto-
mycin (100 ug/mL, Gibco
� BRL) and 10% fetal bovine
serum, and grown at 37� , in an atmosphere containing 5%
carbon dioxide. On the 6th day of culture, half of the super-
natant was eliminated, and the media was changed every 2
or 3 days. Then cell aggregates were obtained at intervals
up to twenty days (14~20 days, mean=16 days) for primary
culture. To obtain enough cells, MSCs were suspended and
sub-cultured. As soon as cultured cells fully filled the bot-
toms of dishes, cells were suspended and centrifuged. The
cultured MSCs were cryopreserved at-70�and thawed for
experiments. 
3. Induction of osteogenesis from cultured MSCs
The frozen MSCs were thawed and suspended in DMEM-
LG solution and 10% fetal bovine serum, and using a cyto-
counter we counted the number of normal shaped stem cells.
For RT-PCR experiments, MSCs were cultivated in 75 cm
2
dishes at a density of 1×106 cells/cm
2. For assays of alka-
line phosphatase activity or chemical staining, MSCs were
cultured in 6-well (10 cm
2) dishes at a density of 3×10
6
cells/cm
2 for 24 hours, and mixed with osteogenesis induc-
ing materials, such as 100 nM dexamethasone (Sigma
�
Chemical, USA), 0.05 mM L-ascorbic acid-2-phosphate
(Gibco
� BRL) and 10 mM beta-glycerophosphate (Sigma
�
Chemical).
The MSCs used for the control experiment were cultivat-
ed in a similar manner but with DMEM-LG solution and
10% fetal bovine serum only, without the presence of osteo-
genesis inducing materials. 
4. Evaluation of osteogenic potential
A. Mineral staining (von Kossa method)
Selected specimens were subsequently stained for mineral
deposits by the von Kossa method
15. Phase contrast
microscopy demonstrates the von Kossa staining mineral.
B. Osteoblast-specific gene expression in RT-PCR
Isolation of total RNA was performed using Trizol solu-
tion (Life technologies, USA) by a modification of the
method of Cassiede et al.
16. Electrophoresis of specimens
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15 uL of PCR products and 2 uL of 6×loading buffer. We
examined the amplified products under a UV-Trans illumi-
nator after staining with 1 ug/mL Et Br (Ethidium Bromide;
Sigma
� Chemical, USA). 
C. The assay of alkaline phosphatase activity 
Cultured osteogenic progenitor cells were rinsed with
Tyrode’s solution twice. Alkaline phosphatase activity, an
index of osteoblastic differentiation, was assayed by the
EIA method
15. 
5. Chromosomal analysis of cultured MSCs
Chromosomal analysis was performed with a modifica-
tion of the method of Moorhead
9. The cytovision system
was used to analyze karyotypes. The normal karyotype was
noted by G-banding. No specific chromosomal abnormality
was observed during culture, subculture and cryopreserva-
tion.
6. Statistical analysis
The results are expressed as mean with standard deviation.
We analyzed the differences in the expression of osteocalcin
and the activity of alkaline phosphatase between the osteo-
porotic and the non-osteoporotic group using the Mann-Whit-
ney test. We investigated 25 samples, regardless of groups, to
determine the correlation between the activity of alkaline
phosphatase of bone marrow-derived MSCs and BMD of
femoral neck, and between the activity of alkaline phos-
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Table 1. Summary of the data 
No Sex Age (years) Femoral neck Alkaline phosphatase (u/L) Alkaline phosphatase (u/L)
BMD (g/cm
2) at the 3rd week after the at the 4th week after the
induction of osteogenesis  induction of osteogenesis
Non-osteoporotic, control group (16 samples)
#10 F 59 0.750 151 145
#20 F 56 0.792 123 070
#30 F 69 0.914 168 151
#40 F 52 0.756 132 145
#50 F 65 0.803 162 140
#60 M 67 0.703 050 079
#70 M 38 1.013 144 164
#80 M 40 0.759 130 070
#90 F 55 0.636 140 128
#10 M 35 1.044 130 154
#11 M 21 0.873 149 154
#12 M 57 0.899 137 153
#13 F 63 0.692 150 129
#14 M 57 0.597 111 139
#15 M 55 0.850 164 142
#16 F 63 0.647 144 150
Mean±SD 59.3 0.795±0.13 136±27 132±30
Osteoporotic group (9 samples)
#10 F 64 0.545 028 025
#20 F 61 0.777 023 030
0 #30 F 72 0.723 039 078
#40 M 44 0.784 070 080
#50 F 68 0.606 025 080
#60 F 21 0.682 039 023
#70 F 59 0.797 060 037
#80 F 59 0.609 074 042
#90 F 63 0.691 048 076
Mean±SD 56.8 0.690±0.09 45±19 52±25
BMD: bone mineral density.phatase of bone marrow-derived MSCs and age. Statistical
analyses were performed using SPSS (version 12.0, Korean).
Results
1. Bone mineral density of the non-osteoporotic con-
trol group and the osteoporotic group
The average BMD of the femoral neck region in the non-
osteoporotic control group (16) was 0.759±0.13 g/cm
2; in
the osteoporotic group (9) it was 0.690±0.09 g/cm
2. The
difference between groups was statistically significant
(p<0.05).
2. Culture of bone marrow-derived MSCs and induc-
tion of osteogenesis
After 2 weeks of culture, an adequate number of MSCs
were achieved in the dishes (75 cm
2). After adding osteoge-
nesis inducing materials, bone formation was induced (Fig.
1) and reached peak level by the 3rd week after the induc-
tion of osteogenesis (Table 1). Bone formation, however,
was not induced in the MSCs unless osteogenesis inducing
materials were added. 
3. Mineral staining 
By the 3rd week after the induction of osteogenesis, there
was a positive result of mineral staining, which increased
with time. There were a number of dark stains of mineral
deposition in the non-osteoporotic, control group (Fig. 2A).
In contrast, there was a scanty matrix mineral deposition in
the osteoporotic group (Fig. 2B).  
4. Osteoblast-specific gene expression in RT-PCR
The expression of osteogenic specific genes in RT-PCR,
such as Type I collagen, Osteocalcin and Osteopontin, pro-
teins that exist only in osteoblasts, reached peak levels by
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Fig. 1. Photomicroscopic findings of the induction of osteogenesis from bone marrow-derived MSCs (400
×). Mesenchymal stem cells from bone marrow were cultured at the 2nd week (A). Other figures are for
the 1st week (B), the 3rd week (C) and the 4th week (D) after the induction of osteogenesis. Bone forma-
tion increased prominently at the 3rd week.
A
CD
Bthe 3rd & 4th weeks after the induction of osteogenesis, and
then decreased slightly (Fig. 3). In the electrophoresis of
PCR products, the expression of Osteocalcin in the osteo-
porotic group was 1.5 to 3 times less than in the non-osteo-
porotic control group (Fig. 4).
5. Alkaline phosphatase activity of bone marrow-
derived MSCs 
Quantitative assays of alkaline phosphatase activity in the
non-osteoporotic, control group, showed that peak levels
were reached by the 3rd & 4th weeks after the induction of
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Fig. 2. The von Kossa stain for matrix mineral deposition (400×). Matrix mineral deposition confirmed at
the 3rd week after the induction of osteogenesis. The staining of the non-osteoporotic control group (A)
was denser than the staining in the osteoporotic group (B). 
AB
Fig. 3. Osteoblast-specific gene expression in RT-PCR.  Type I
collagen, Osteocalcin and Osteopontin in RT-PCR increased
by the 3rd & 4th weeks after the induction of osteogenesis.
Fig. 5. Quantitative assay of alkaline phosphatase activity
(U/L) in bone marrow-derived MSCs. The non-osteoporotic
control group (n=16) showed that alkaline phosphatase activity
reached peak levels by the 3rd & 4th weeks after induction.
Fig. 4. The expression of osteocalcin in [[the electrophoresis of
RT-PCR]]. The expression of osteocalcin in the osteoporotic
group (O) was 1.5 to 3 times less than in the non-osteoporotic
control group (C). (n=3, O: Osteoporotic group, N: Non osteo-
genesis induced group, C: Control, non-osteoporotic group *p
<0.05, **p<0.01)osteogenesis, and abruptly decreased thereafter (Fig. 5). In
the non-osteoporotic control group, alkaline phosphatase
activity was 136±7 U/L by the 3rd week, and 132±30 U/L
at the 4th week after the induction of osteogenesis. In the
osteoporotic group, alkaline phosphatase activity was 45±
19 U/L at the 3rd week, and 52±25 U/L at the 4th week
after the induction of osteogenesis (Fig. 6).  
6. Correlation between alkaline phosphatase activity
of bone marrow-derived MSCs and femoral neck
BMD 
Alkaline phosphatase activity increased as femoral neck
BMD increased by the 3rd & 4th weeks after the induction
of osteogenesis. There was a statistically significant and
positive correlation between femoral neck BMD & alkaline
phosphatase activity by the 3rd & 4th weeks after the induc-
tion of osteogenesis (r=0.487, 3rd week; r=0.501, 4th week)
(Fig. 7).
7. Correlation between alkaline phosphatase activity
of bone marrow-derived MSCs and age 
The mean age of the osteoporotic group (9) was 56.8; it
was lower than the mean age, 59.3, of the control group
(16). There was no statistically significantly correlation
between the patients’age and their alkaline phosphatase
activity at the 3rd & 4th weeks after the induction of osteo-
genesis (r=-0.169, 3rd week; r=-0.086, 4th week) (Fig. 8).
Discussion
Bone marrow-derived MSCs which originate from stro-
mal tissue are undifferentiated progenitor cells that have the
pluripotentiality to differentiate into osteogenic cells, chon-
drogenic cells, adipose tissue, fibroblasts and reticular
cells
17. After culturing and the proliferation of osteogenic
progenitor cells, they can be clinically implanted into the
bone defect of nonunion and around orthopaedic implants
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Fig. 6. Comparison of alkaline phosphatase activity (U/L) in
bone marrow-derived MSCs between the osteoporotic group
(n=9) and the non-osteoporotic group (n=16). The osteoporotic
group showed lower alkaline phosphatase activities than the
non-osteoporotic control group.
Fig. 7. Scatter plot for the relationship between the bone mineral density (BMD) and alkaline phosphatase activity. There was a sta-
tistically significant and positive correlation between BMD and alkaline phosphatase activity by the 3rd & 4th weeks after the induc-
tion of osteogenesis. R: correlation efficient.for bone healing
17,18. In addition, cells from bone marrow
can be cultured and differentiated in vitro and utilized to
diagnose the osteogenic potential of donors
2,3. Generally, the
change of bone mass arises from the imbalance of coupling
of bone formation to bone resorption, and bone mineral
density is easily used for measuring of bone mass clinically.
If we know the osteogenic potential in patients who will
expect a pseudoarthrosis of spinal fusion, it may provide
useful information to clinicians so that they can decide on
proper treatment strategies. Is it possible to use bone miner-
al density for evaluation of osteogenic potential of the host
as an osteogenic potential of cultured MSCs? 
Many studies have been performed to examine the corre-
lation between osteogenic potenial of in vitro cultured
MSCs and aging
10,19. D’Ippolito et al.
10 reported that the
number of MSCs with osteogenic potential decreases early
during aging in humans and may be responsible for the age-
related reduction in osteoblastic number. Oreffo et al.
20 sug-
gested that reduction in bone mass with aging may be due
to reduction of the proliferative capacity of progenitor cells
or their responsiveness to biological factors, and result in
alterations in subsequent differentiation. In contrast, some
studies have shown that the number and differentiation
capacity of osteogenic stem cells is maintained with
aging
12,13. The present study found no significant correlation
between alkaline phosphatase activity and aging. It is gener-
ally accepted that the degeneration of osteogenic progenitor
cells occurs with aging. Considering that a few old patients
maintain good bone mass, however, this author would sug-
gest that the evaluation of osteogenic potential is relevant
when bone mass is assessed by BMD rather than by age.
Osteoporosis is a condition of decreased bone mass lead-
ing to reduced bone density. Justesen et al.
21 reported that
MSCs maintain their differentiation potential during aging
and in patients with osteoporosis. However, many authors
reported a reduction in the number of osteogenic progenitor
cells, leading to reductions in osteoblast number and alka-
line phosphatase activity in osteoporosis
10,11,19,20,22. Rodriguez
et al.
23 reported that osteoporotic and control stem cells have
similar morphology and size and express similar cell sur-
face antigens, but MSCs from osteoporotic women differ
from controls in having a lower growth rate than control
cells, being refractory to the mitogenic effect of IGF-1, and
being less able to differentiate into the osteogenic lineage as
evidenced by alkaline phosphatase activity. In this study,
MSCs in the osteoporotic group differentiated into
osteoblasts, but their potential to differentiate decreased sig-
nificantly more than did the control group, as evidenced by
alkaline phosphatase activities by the 3rd & 4th weeks after
induction of osteogenesis (p<0.05). In all 25 specimens,
however, a positive correlation between femoral neck BMD
and alkaline phosphatase activity was observed (p<0.05). A
similar correlation was shown in osteoblast-specific gene
expression by RT-PCR. 
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Fig. 8. Scatter plot for the relationship between patient’s age and alkaline phosphatase activity. There was a negative correlation
between the patient’s age and the alkaline phosphatase activity at the 3rd & 4th weeks after the induction of osteogenesis but it was
not is no statistically significant. R: correlation efficient.This study had limitations. First, we did not measure
number and colony forming units of MSCs, which are tradi-
tional methods for evaluating osteogenic potentials. As
number and colony forming units of MSCs are commonly
obtained by the treating researchers, they can lead to bias in
analyzing the data. We assayed the activity of alkaline
phosphatase of cultured MSCs in vitro as a way of doing
quantitative analysis of osteoblastic differentiation instead
of investigating the number and colony forming units of
MSCs. Second, we did not analyze the distribution of age
and sex between the two groups to compare outcomes.
Third, there was small case. 
Considering the positive correlation between BMD and
the osteogenic potential of bone marrow-derived MSCs, the
osteogenic potential of patients can be predicted by mea-
surement of their BMD. To provide more evidence for a
correlation between BMD and the osteogenic potential of
MSCs, however, it will be necessary to run additional, clini-
cally relevant studies such as ones on the relation between
pseudoarthrosis and bone mineral density, and risk guidance
of bone mineral density for a pseudoarthrosis. 
Conclusions
In the present study, in vitro osteogenesis was successful-
ly induced from bone marrow-derived mesenchymal stem
cells, and the osteogenic potential of MSCs decreased in
osteoporotic patients. The study revealed a positive correla-
tion between bone mineral density and osteogenic potential
from MSCs. The measurement of BMD can thus provide
supplementary data for evaluating osteogenic potential clin-
ically. 
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